Using ramipril as a model active pharmaceutical ingredient, the focus of the present study was to fabricate low-cost controlled release tablets using combinations of biopolymer and semi-synthetic polymers. Cellulose derivatives are more viscous where biopolymers form gels more easily. Xanthan gum can’t shape a solid gel, result in fragmentation of gel around the tablets so that depend upon high concentration. Therefore, a combination was used to formulate tablet by direct compression. This combination of polymer provides low cost product with higher potentiality. Ingredients as per formulations were mixed in small polybag through hand blending. Then tablets were compressed one by one tablet in a hydraulic press. Prepared tablets were evaluated for hardness, weight variation, content uniformity, friability, surface pH and in-vitro dissolution studies. ANOVA was used to analyze the differences between release data. Swelling index, mucoadhesive strength and in-vitro residence time was studied to show gastroretention of the tablets. Formulated products exhibit sufficient quality and strength to formulate as a mucoadhesive tablet. Significant differences were found in drug release among different formulations (p ˂0.05) in all cases. Among all of formulations, F11, F12 and F13 containing different ratio of xanthan gum and guar gum showed promising mucoadhesive strength and in-vitro residence time.
___
[1] Patel SB, Murthy RSR, Mahan HS, Wagh RD, Gattani SG. Mucoadhesive polymers: Means of improving drug delivery. Pharma Times. 2006; 38(4): 25-28.
[2] Parmar H, Bakliwal S, Gujarathi N, Rane B, Pawar S. Different method of formulation and evaluation of mucoadhesive microsphere. Int J Appl Biol Pharm. 2010; 1(3): 1157-1167.
[3] Chen YC, Ho HO, Liu DZ, Siow WS, Sheu MT. Swelling/floating capability and drug release characterizations of gastroretentive drug delivery system based on a combination of hydroxyethyl cellulose and sodium carboxymethyl cellulose. PLoS One. 2015; 10(3).
[4] Martínez IJ, Barreda TQ, Robles LV. Sustained delivery of captopril from floating matrix tablets. Int J Pharm. 2008; 362: 37–43.
[5] Varshosaz J, Tavakoli N, Roozbahani F. Formulation and in vitro characterization of ciprofloxacin floating and bioadhesive extended-release tablets. Drug Deliv. 2006; 13: 277–285.
[6] Strübing S, Metz H, Mäder K. Characterization of poly (vinyl acetate) based floating matrix tablets. J Control Release. 2008; 126: 149–155.
[7] Mulye N, Kavita I. Sustain release tablets containing hydrocolloid and cellulose ether. US Pat 6416786, 2002.
[8] Sujja-Areevath J, Munday DL, Cox PJ, Khan KA. Relationship between swelling, erosion and drug release in hydrophilic natural gum mini-matrix formulations. Eur J Pharm Sci. 1998; 6(3): 207-217.
[9] Baveja SK, Ranga Rao KV, Devi KP. Zero-order release hydrophilic matrix tablets of β-adrenergic blockers. Int J Pharm. 1987; 39(1): 39-45.
[10] Ranga Rao KV, Devi KP, Buri P. Influence of molecular size and water solubility of the solute on its release from swelling and erosion controlled polymeric matrices. J Control Release. 1990; 12(2): 133-141.
[11] Van Griensven JMT, Schoemaker RC, Cohen AF, Luus HG, Seibert-Grafe M, Röthig HJ. Pharmacokinetics, pharmacodynamics and bioavailability of the ACE inhibitor ramipril. Eur J Clin Pharmacol. 1995; 47(6): 513–518.
[12] Gawali P, Gupta A, Kachare S, Kshirsagar S. Formulation and evaluation of matrix-based sustained release tablets of quetiapine fumarate and the influence of excipients on drug release. J Chem Pharm Res. 2012; 4(6): 3073-3081.
[13] Kotadiya R, Patel V, Patel H. Comparative evaluation study of matrix properties of natural gums and semisynthetic polymer. J Pharm Res. 2008; 1(2): 208-214.
[14] Bhalla H, Sanzgiri YD. An improved controlled release tablet of salbutamol sulphate. Indian J Pharm Sci. 1987; 49(1): 22-25.
[15] Varshosaz J, Tavakoli N, Kheirolahi F. Use of hydrophilic natural gums in formulation of sustained-release matrix tablets of tramadol hydrochloride. AAPS Pharm Sci Tech. 2006; 7(1): 168-174.
[16] Altaf SA, Yu K, Parasrampuria J, Friend DR. Guar gum based sustained release diltiazem. Pharm Res. 1998; 15(8): 1196-1201.
[17] Umarji B, Patil R, Birajdar R, Mysore S, Bilagi S, Audurti D. Formulation and in vitro evaluation of mucoadhesive buccal tablet of Furosemide. World J Pharm Sci. 2012; 1(3): 1041-1063.
[18] Sato H, Miyagawa Y, Okabe T, Mityajima M, Suanada H. Dissolution mechanism of diclofenac sodium from wax matrix granules. J Pharm Sci. 1997; 86(8): 929-934.
[19] Ritger PL, Pappas NA. A Simple equation for description of solute release II. Fickian and anomalous release from swellable devices. J Control Release. 1987; 5(1): 37-42.
[20] Hossain MS, Banik S, Islam MS. Formulation design and characterization of Kollidon SR based trimetazidine dihydrochloride matrix tablets. Indian J Pharm Educ Res. 2012; 46(2): 137-144.
[21] Gupta MM, Saini TR. Preformulation parameters characterization to design, development and formulation of Vancomycin hydrochloride tablets for pseudomembranous colitis. Int J Pharm Res Dev. 2009; 1(9): 17.
[22] Bottenbarg P, Cleymaet R, De Muyanek C, Remon JP, Coomans D, Michotte Y, Slop D. Development and testing of bioadhesive, fluoride-containing slow-release tablets for oral use. J Pharm Pharmacol. 1991; 43(7): 457-464.
[23] Kulkarni RV, Shah A, Boppana R. Development andevaluation of xyloglucan matrix tablets containing naproxen. Asian J Pharm. 2008; 2(2): 102-105.
[24] Shanker G, Kumar CK, Gonugunta CSR, Kumar BV, Veerareddy PR. Formulation and evaluation of bioadhesive buccal drug delivery of Tizanidine hydrochloride tablets. AAPS Pharm Sci Tech. 2009; 10(2): 530-539.
[25] Pandey S, Gupta A, Yadav JS, Shah DR. Formulation and in vitro evaluation of bilayered buccal tablets of Carvedilol. Indian J Pharm Educ Res. 2010; 44(3): 7-14.